Stay updated on EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page.

Latest updates to the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new history entry for version 82 was added on 2026-07-07, with an accompanying Study Status update around 2026-07-09, and an older entry dated 2026-05-07 was deleted.SummaryDifference0.2%

- Check16 days agoChange DetectedThe record history now displays the latest platform revision as v3.6.3, replacing the previous v3.6.2 entry. This indicates a minor system release in the history view rather than a modification to the study information.SummaryDifference0.0%

- Check23 days agoChange DetectedA new site revision tag v3.6.2 was added, replacing v3.6.0, indicating a minor platform update reflected in the page's revision history.SummaryDifference0.0%

- Check37 days agoChange DetectedA new note states that recruitment is no longer ongoing, and the revision history has been updated to v3.6.0 with v3.5.5 removed, reflecting an administrative update to the record's versioning.SummaryDifference0.2%

- Check44 days agoChange DetectedThe page shows a new revision label (v3.5.5) indicating an administrative update to the record history.SummaryDifference0.0%

- Check66 days agoChange DetectedThe history now shows a new revision entry (v3.5.4) replacing the previous one (v3.5.3), indicating an update to the record metadata.SummaryDifference0.0%

Stay in the know with updates to EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page.